Nektar Therapeutics
NKTR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000906709
In the last 90 days, Nektar Therapeutics insiders filed 0 open-market purchases and 2 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Nektar Therapeutics as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 123
- −3 vs. Q4 2023
- Shares held
- 113.0M
- −6.23M (−5.2%) vs. Q4 2023
- Total value
- $105.5M
- +$38.2M (+56.7%) vs. Q4 2023
- New holders
- 16
- 20 more added
- Sold out
- 19
- 49 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NKTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 239 | $2.50B |
| Q1 2026 | 216 | $1.94B |
| Q4 2025 | 180 | $732.2M |
| Q3 2025 | 153 | $820.2M |
| Q2 2025 | 109 | $197.7M |
| Q1 2025 | 157 | $84.2M |
| Q4 2024 | 146 | $123.6M |
| Q3 2024 | 140 | $182.9M |
| Q2 2024 | 135 | $168.0M |
| Q1 2024 | 123 | $105.5M |
| Q4 2023 | 127 | $67.3M |
| Q3 2023 | 139 | $85.3M |
| Q2 2023 | 148 | $79.3M |
| Q1 2023 | 197 | $121.2M |
| Q4 2022 | 217 | $381.7M |
| Q3 2022 | 232 | $561.4M |
| Q2 2022 | 230 | $693.8M |
| Q1 2022 | 243 | $947.6M |
| Q4 2021 | 242 | $2.35B |
| Q3 2021 | 243 | $3.01B |
| Q2 2021 | 243 | $2.89B |
| Q1 2021 | 239 | $3.40B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Nektar Therapeutics; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Compass Wealth Management LLC | 2,000 | $1.87K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 1,500 | $1.40K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 1,256 | $1.17K | 0.00% | 00.0% | Unchanged |
| Founders Capital Management | 700 | $654 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 631 | $589 | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 500 | $467 | 0.00% | 00.0% | Unchanged |
| WealthCollab, LLC | 300 | $281 | 0.00% | 00.0% | Unchanged |
| AllSquare Wealth Management LLC | 277 | $259 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 200 | $187 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 200 | $187 | 0.00% | 00.0% | Unchanged |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 200 | $186 | 0.00% | +200 | New |
| Versant Capital Management, Inc | 169 | $158 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 155 | $145 | 0.00% | 00.0% | Unchanged |
| Princeton Global Asset Management LLC | 100 | $93 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 78 | $73 | 0.00% | −357,636−100.0% | Reduced |
| Salomon & Ludwin, LLC | 46 | $43 | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 40 | $37 | 0.00% | −23,765−99.8% | Reduced |
| Assetmark, Inc | 22 | $21 | 0.00% | +22 | New |
| Global Retirement Partners, LLC | 16 | $15 | 0.00% | 00.0% | Unchanged |
| Huntington National Bank | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 340 | $0 | 0.00% | −401−54.1% | Reduced |
| CWM, LLC | 250 | $0 | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 25 | $0 | 0.00% | −45−64.3% | Reduced |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −2,348,109−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −73,212−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −70,500−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −30,224−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −21,535−100.0% | Sold out |
| Freestone Capital Holdings, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −19,400−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −14,622−100.0% | Sold out |
| Cetera Advisors LLC | 0 | $0 | 0.00% | −12,300−100.0% | Sold out |
| Confluence Wealth Services, Inc. | 0 | $0 | 0.00% | −11,685−100.0% | Sold out |
| Choate Investment Advisors | 0 | $0 | 0.00% | −11,580−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −10,284−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,819−100.0% | Sold out |
| Atlas Capital Advisors LLC | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| PFS Partners, LLC | 0 | $0 | 0.00% | −597−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| McClarren Financial Advisors, Inc. | 0 | $0 | 0.00% | −157−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −362−100.0% | Sold out |
| Strategic Investment Solutions, Inc. | – | – | – | – | Not filed |